RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10

FDA recall notice · announced March 14, 2018 · Mckesson Packaging Services

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10

Reason for recall

Failed Stability Specifications

Notes

Distribution: Nationwide
Lot/code information: Lots: 0113064 Exp. 03/2018, 0114628 Exp. 08/2018, 0115189 Exp. 08/2018, 0115462 Exp. 09/2018
Quantity: 17,192 cartons (1,719,200 tablets)
Status: Terminated
Products in this recall event:
- RANITIDINE Tablets, USP 150 mg UD 100 tablets (10x10), RX Only, Manufactured by: Amneal Pharmaceuticals, Hauppauge, NY 11788, NDC 63739-489-10 (D-0914-2018)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.